摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Methyl 14-oxotetradeca-5,8,11-trienoate | 86255-54-1

中文名称
——
中文别名
——
英文名称
Methyl 14-oxotetradeca-5,8,11-trienoate
英文别名
methyl 14-oxotetradeca-5,8,11-trienoate
Methyl 14-oxotetradeca-5,8,11-trienoate化学式
CAS
86255-54-1
化学式
C15H22O3
mdl
——
分子量
250.338
InChiKey
WXEIGUDMESHTJO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    352.7±42.0 °C(Predicted)
  • 密度:
    0.971±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    18
  • 可旋转键数:
    11
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:a6d22831b3102acfafe1c43d96d6206b
查看

反应信息

  • 作为反应物:
    描述:
    Methyl 14-oxotetradeca-5,8,11-trienoate苄基三苯基鏻碘化物正丁基锂 作用下, 以 四氢呋喃 为溶剂, 生成 methyl (5Z,8Z,11Z,14Z)-16-phenylhexadeca-5,8,11,14-tetraenoate
    参考文献:
    名称:
    Development of novel tail-modified anandamide analogs
    摘要:
    To explore the hydrophobic groove subsite within the CB1 cannabinoid receptor we have designed and synthesized a group of tail-substituted anandamide analogs. Our design involves the introduction of aryl or heterocyclic ring as terminal substituents that are connected to the last cis-arachidonyl double bond through aliphatic chains of variable lengths. Our results indicate that there are strict stereochemical requirements for the interaction of such analogs with the CB1 receptor. The optimal pharmacophore includes the phenyl, p-substituted phenyl, or 3-furyl substituents attached to the cis-double bond through a four methylene chain. Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmcl.2008.07.110
  • 作为产物:
    描述:
    (5Z,8Z,11Z)-methyl 14-hydroxytetradeca-5,8,11-trienoate 在 戴斯-马丁氧化剂 作用下, 以 二氯甲烷 为溶剂, 反应 0.5h, 以86%的产率得到Methyl 14-oxotetradeca-5,8,11-trienoate
    参考文献:
    名称:
    Development of novel tail-modified anandamide analogs
    摘要:
    To explore the hydrophobic groove subsite within the CB1 cannabinoid receptor we have designed and synthesized a group of tail-substituted anandamide analogs. Our design involves the introduction of aryl or heterocyclic ring as terminal substituents that are connected to the last cis-arachidonyl double bond through aliphatic chains of variable lengths. Our results indicate that there are strict stereochemical requirements for the interaction of such analogs with the CB1 receptor. The optimal pharmacophore includes the phenyl, p-substituted phenyl, or 3-furyl substituents attached to the cis-double bond through a four methylene chain. Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmcl.2008.07.110
点击查看最新优质反应信息

文献信息

  • Development of novel tail-modified anandamide analogs
    作者:Fenmei Yao、Chen Li、Subramanian K. Vadivel、Anna L. Bowman、Alexandros Makriyannis
    DOI:10.1016/j.bmcl.2008.07.110
    日期:2008.11
    To explore the hydrophobic groove subsite within the CB1 cannabinoid receptor we have designed and synthesized a group of tail-substituted anandamide analogs. Our design involves the introduction of aryl or heterocyclic ring as terminal substituents that are connected to the last cis-arachidonyl double bond through aliphatic chains of variable lengths. Our results indicate that there are strict stereochemical requirements for the interaction of such analogs with the CB1 receptor. The optimal pharmacophore includes the phenyl, p-substituted phenyl, or 3-furyl substituents attached to the cis-double bond through a four methylene chain. Published by Elsevier Ltd.
查看更多